Questions About H1N1 Vaccination and GBS? Webinar Now Offers Vital Information

All Neurologists Should Maintain Vigilance for GBS Nationwide

November 9, 2009

Share:

As part of the AAN's ongoing collaboration with the CDC to educate neurologists and health care professionals about H1N1 vaccination and Guillain-Barré syndrome (GBS), AAN.com now offers a recording of the October 21 webinar, "Guillain Barré Syndrome and the Influenza Vaccine." Use your browser to stream the audio-visual presentation, as it took place with a live online audience.

In addition to the webinar, AAN.com offers a wide range of online tools as part of the nationwide effort to make health care professionals aware of the campaign to report any possible new cases of GBS following 2009 H1N1 flu vaccination using the CDC and US Food and Drug Administration Vaccine Adverse Event Reporting System (VAERS). Find everything you need to participate in the monitoring campaign in one place: the Reporting Toolkit for GBS.

The GBS Toolkit page:

This page includes regular updates designed to keep you informed, with the latest news of the national monitoring campaign.

Do You Practice in an Emerging Infections Program (EIP) State?

To aid the CDC in evaluating the safety of the novel H1N1 vaccine, CDC's Emerging Infections Program (EIP) and the AAN have asked neurologists, hospitalists, emergency medical physicians, and other health care professionals in 10 states (CT, MD, MN, NM, TN, CA, and selected regions of CO, GA, NY, and OR) to practice increased vigilance with their patients and to report any possible new cases of GBS, regardless of vaccination, to their state's surveillance officer.

Your active involvement is extremely important. The request for heightened GBS surveillance in these states is a strategy for increased detection.

Visit the EIP Resource page to find out more about surveillance in your state.